Marien M R, Parsons S M, Altar C A
Proc Natl Acad Sci U S A. 1987 Feb;84(3):876-80. doi: 10.1073/pnas.84.3.876.
2-(4-Phenylpiperidino)cyclohexanol (AH5183) is a noncompetitive and potent inhibitor of high-affinity acetylcholine transport into cholinergic vesicles. It is reported here that [3H]AH5183 binds specifically and saturably to slide-mounted sections of the rat forebrain (Kd = 1.1 to 2.2 X 10(-8) M; Bmax = 286 to 399 fmol/mg of protein). The association and dissociation rate constants for [3H]AH5183 binding are 8.6 X 10(6) M-1 X min-1 and 0.18 min-1, respectively. Bound [3H]AH5183 can be displaced by nonradioactive AH5183 and by the structural analog (2 alpha,3 beta,4A beta,8A alpha)-decahydro-3-(4-phenyl-1-piperidinyl)-2- naphthalenol but not by 10 microM concentrations of the cholinergic drugs acetylcholine, choline, atropine, hexamethonium, eserine, or hemicholinium-3 or by the structurally related compounds 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenylpyridine, (+/-)-N-allylnormetazocine (SKF 10,047), levoxadrol, or dexoxadrol. Quantitative autoradiography reveals that [3H]AH5183 binding sites are distributed heterogenously throughout the rat forebrain and are highly localized to cholinergic nerve terminal regions. At the level of the caudate nucleus-putamen, the highest concentrations of saturable [3H]AH5183 binding (713-751 fmol/mg of protein) are found in the vertical limb of the diagonal band and the olfactory tubercle, with lesser amounts (334-516 fmol/mg of protein) in the caudate-putamen, nucleus accumbens, superficial layers of the cerebral cortex, and the primary olfactory cortex. At day 7 after transsection of the left fimbria, [3H]AH5183 binding and choline acetyltransferase activity in the left hippocampus were reduced by 33 +/- 6% and 61 +/- 7%, respectively. These findings indicate that [3H]AH5183 binds to a unique recognition site in rat brain that is topographically associated with cholinergic nerve terminals.
2-(4-苯基哌啶基)环己醇(AH5183)是一种非竞争性的强效抑制剂,可抑制高亲和力乙酰胆碱转运至胆碱能囊泡中。本文报道,[3H]AH5183能特异性且饱和地结合于大鼠前脑的载玻片切片上(Kd = 1.1至2.2×10(-8)M;Bmax = 286至399 fmol/mg蛋白质)。[3H]AH5183结合的缔合和解离速率常数分别为8.6×10(6)M-1×min-1和0.18 min-1。结合的[3H]AH5183可被非放射性的AH5183和结构类似物(2α,3β,4Aβ,8Aα)-十氢-3-(4-苯基-1-哌啶基)-2-萘酚取代,但不能被10 microM浓度的胆碱能药物乙酰胆碱、胆碱、阿托品、六甲铵、毒扁豆碱或半胱氨酸-3取代,也不能被结构相关化合物1-甲基-4-苯基-1,2,3,6-四氢吡啶、1-甲基-4-苯基吡啶、(±)-N-烯丙基去甲左啡诺(SKF 10,047)、左旋氧代二氢吗啡酮或右旋氧代二氢吗啡酮取代。定量放射自显影显示,[3H]AH5183结合位点在大鼠前脑中分布不均一,且高度定位于胆碱能神经末梢区域。在尾状核-壳核水平,可饱和的[3H]AH5183结合最高浓度(713 - 751 fmol/mg蛋白质)见于斜角带垂直支和嗅结节,尾状核-壳核、伏隔核、大脑皮层浅层和初级嗅皮层中的含量较少(334 - 516 fmol/mg蛋白质)。在左侧穹窿横断后第7天,左侧海马中的[3H]AH5183结合和胆碱乙酰转移酶活性分别降低了33±6%和61±7%。这些发现表明,[3H]AH5183结合于大鼠脑中一个独特的识别位点,该位点在地形学上与胆碱能神经末梢相关。